Form 4: Claritev CEO Dalton Reports Significant Equity Transactions

Claritev Corp's President and CEO, Travis Dalton, reported routine insider transactions including new restricted stock unit grants, tax-related share dispositions, and cash settlement of cRSUs.

Summary

• Travis Dalton, President, CEO, and Executive Chair of Claritev Corp, reported several transactions on March 1, 2026.
• Disposed of 13,806 shares of Class A common stock at $13.47 per share to cover tax obligations related to restricted stock units (RSUs) granted on March 1, 2024.
• Disposed of an additional 9,824 shares of Class A common stock at $13.47 per share for tax obligations related to RSUs granted on March 1, 2025.
• Acquired 278,925 new restricted stock units (RSUs) at a price of $0, which will vest at 25% per year on March 1, 2027, 2028, 2029, and 2030.
• Disposed of 190,566 cash-settled restricted stock units (cRSUs) due to the vesting and cash settlement of 50% of cRSUs granted on March 1, 2025.
• Following these transactions, Dalton directly owns 498,353 shares of Class A common stock and indirectly owns 24,952 shares through a spouse's Individual Retirement Account.
• Dalton also directly holds 190,567 derivative securities (cRSUs).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing. While there are dispositions for tax purposes and cash settlement of some units, the significant new grant of restricted stock units demonstrates continued long-term commitment and incentive for the CEO.

Positives

• Grant of 278,925 new restricted stock units (RSUs) indicates continued long-term incentive for the CEO, aligning his interests with future company performance.

Negatives

• Disposition of 23,630 shares (13,806 + 9,824) of Class A common stock to cover tax liabilities, reducing direct equity holdings.
• Cash settlement of 190,566 cash-settled restricted stock units (cRSUs) means these units did not convert to equity shares, potentially limiting direct alignment with share price appreciation for those specific units.

Future Outlook

The filing details future vesting schedules for newly granted restricted stock units, with 25% vesting annually from March 1, 2027, through March 1, 2030, indicating a long-term incentive structure for the CEO.

Industry Context

StockSavvy.ai notes that these transactions are typical for executive compensation packages in the technology and corporate services sectors, often involving a mix of equity grants and cash-settled awards designed to align management incentives with long-term company performance while managing tax liabilities.

Stakeholder Impact

• Shareholders: The new RSU grant aligns the CEO's long-term interests with shareholder value creation. Tax-related dispositions are routine and expected.
• Employees: These transactions reflect standard executive compensation practices, which can influence broader compensation strategies within the company.

Next Steps

• Vesting of 25% of the 278,925 newly granted restricted stock units on March 1, 2027.
• Subsequent annual vesting of 25% of these RSUs on March 1, 2028, March 1, 2029, and March 1, 2030.

Key Dates

Recommendation

This Form 4 details routine insider transactions related to executive compensation, including RSU grants, vesting, and tax-related share dispositions. While the new RSU grant is a positive sign of continued alignment, these transactions are not indicative of a fundamental shift in the company's prospects or valuation that would warrant a 'buy' or 'sell' recommendation based solely on this filing. Investors should 'hold' and consider these transactions as part of the ongoing compensation structure.

Keywords

Claritev Corp, CTEV, Travis Dalton, Insider Trading, Form 4, Restricted Stock Units, RSU, Cash Settled RSU, Equity Compensation, CEO, Director, Officer